Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

Recruiting

Phase 2

CPX-351Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

Sponsor:

St. Jude Children's Research Hospital

Code:

NCT05656248

Conditions

Myeloid Neoplasm

Eligibility Criteria

Sex: All

Age: 1 - 21

Healthy Volunteers: Not accepted

Interventions

CPX-351

MHA

Allogeneic Hematopoietic Stem Cell Transplantation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by St. Jude Children's Research Hospital on 2025-02-14.